Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Universal Health Services, Inc (NYSE: UHS) closed at $182.56 up 0.17% from its previous closing price of $182.25. In other words, the price has increased by $0.17 from its previous closing price. On the day, 0.66 million shares were traded. UHS stock price reached its highest trading level at $184.05 during the session, while it also had its lowest trading level at $180.9.
Ratios:
For a deeper understanding of Universal Health Services, Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 92.80 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.13. For the most recent quarter (mrq), Quick Ratio is recorded 1.23 and its Current Ratio is at 1.32. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.73.
On March 26, 2025, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $200.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 14 ’25 when Singer Maria Ruderman sold 1,097 shares for $191.48 per share. The transaction valued at 210,053 led to the insider holds 7,884 shares of the business.
Singer Maria Ruderman sold 1,000 shares of UHS for $179,161 on Mar 10 ’25. The Director now owns 7,916 shares after completing the transaction at $179.16 per share. On Mar 10 ’25, another insider, MARIA RUDERMAN SINGER, who serves as the Director of the company, bought 1,000 shares for $179.16 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UHS now has a Market Capitalization of 11764239360 and an Enterprise Value of 16740883456. As of this moment, Universal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.25, and their Forward P/E ratio for the next fiscal year is 8.50. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.80. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.73 while its Price-to-Book (P/B) ratio in mrq is 1.73. Its current Enterprise Value per Revenue stands at 1.041 whereas that against EBITDA is 7.144.
Stock Price History:
The Beta on a monthly basis for UHS is 1.25, which has changed by -0.007556379 over the last 52 weeks, in comparison to a change of 0.12153554 over the same period for the S&P500. Over the past 52 weeks, UHS has reached a high of $243.25, while it has fallen to a 52-week low of $153.99. The 50-Day Moving Average of the stock is -0.09%, while the 200-Day Moving Average is calculated to be -4.33%.
Shares Statistics:
For the past three months, UHS has traded an average of 855.90K shares per day and 906620 over the past ten days. A total of 57.19M shares are outstanding, with a floating share count of 53.87M. Insiders hold about 16.40% of the company’s shares, while institutions hold 85.22% stake in the company. Shares short for UHS as of 1749772800 were 2177443 with a Short Ratio of 2.54, compared to 1747267200 on 2498790. Therefore, it implies a Short% of Shares Outstanding of 2177443 and a Short% of Float of 5.4.
Dividends & Splits
According to the company, the forward annual dividend rate for UHS is 0.80, from 0.8 in the trailing year. Against a Trailing Annual Dividend Yield of 0.0043895748The stock’s 5-year Average Dividend Yield is 0.49. The current Payout Ratio is 4.76% for UHS, which recently paid a dividend on 2025-06-02 with an ex-dividend date of 1748822400. Stock splits for the company last occurred on 2009-12-16 when the company split stock in a 2:1 ratio.
Earnings Estimates
Its stock is currently analyzed by 15.0 different market analysts. The consensus estimate for the next quarter is $4.38, with high estimates of $4.68 and low estimates of $4.04.
Analysts are recommending an EPS of between $20.02 and $19.26 for the fiscal current year, implying an average EPS of $19.54. EPS for the following year is $21.41, with 15.0 analysts recommending between $22.06 and $20.68.
Revenue Estimates
A total of 15 analysts believe the company’s revenue will be $4.24B this quarter.It ranges from a high estimate of $4.29B to a low estimate of $4.18B. As of the current estimate, Universal Health Services, Inc’s year-ago sales were $3.91BFor the next quarter, 15 analysts are estimating revenue of $4.31B. There is a high estimate of $4.39B for the next quarter, whereas the lowest estimate is $4.22B.
A total of 17 analysts have provided revenue estimates for UHS’s current fiscal year. The highest revenue estimate was $17.31B, while the lowest revenue estimate was $16.95B, resulting in an average revenue estimate of $17.13B. In the same quarter a year ago, actual revenue was $15.83BBased on 17 analysts’ estimates, the company’s revenue will be $18.08B in the next fiscal year. The high estimate is $18.65B and the low estimate is $17.7B.
